Active Recombinant Human DRAXIN Protein, His-tagged

• Cat.No.: DRAXIN-874H
• Product Overview: Recombinant Human DRAXIN (Accession # NP_940947) Gly26-Val349, fused with a C-terminal 6-His tag, was produced in Mouse myeloma cell line, NS0-derived.

Specification

• Species: Human
• Source: Mammalian Cells
• Tag: His
• Protein Length: Gly26-Val349
• Predicted N Terminal: Gly26
• Form: Lyophilized from a 0.2 µm filtered solution in PBS with BSA as a carrier protein.
• Bio-activity: Measured by its binding ability in a functional ELISA.When Recombinant Human Draxin is immobilized at 2 µg/mL, Recombinant Human LRP-6 Fc Chimera binds with an apparent KD < 25 nM. Also measured by its ability to enhance neurite outgrowth of E16-E18 rat embryonic cortical neuron.
• Molecular Mass: Recombinant Human DRAXIN, His-tagged has a calculated MW of 36.9 kDa. In SDS-PAGE migrates as 50-60 kDa, reducing conditions.
• Purity: >95%, by SDS-PAGE under reducing conditions and visualized by silver stain.
• Storage: Avoid repeated freeze-thaw cycles. No activity loss was observed after storage at: In lyophilized state for 1 year (4ºC); After reconstitution under sterile conditions for 3 months (-70ºC).
• Reconstitution: Reconstitute at 100 µg/mL in sterile PBS containing at least 0.1% human or bovine serum albumin.

Gene Information

• Gene Name: DRAXIN dorsal inhibitory axon guidance protein [ Homo sapiens ]
• Official Symbol: DRAXIN
• Synonyms: UNQ3119; neucrin; AGPA3119; C1orf187
• Gene ID: 374946
• mRNA Refseq: NM_198545.3
• Protein Refseq: NP_940947.3
• MIM: 612682
• UniProt ID: Q8NBI3
• Chromosome Location: 1p36.22